Ideaya Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $7,000 | $0 | $0 | $0 |
Gross Profit | 7,000 | -1,097 | -1,082 | |
EBITDA | -143,495 | -66,893 | -64,305 | -51,017 |
EBIT | -144,138 | -67,905 | -65,402 | -52,099 |
Net Income | -130,312 | -51,821 | -52,772 | -39,572 |
Net Change In Cash | 7,000 | 0 | 0 | 0 |
Free Cash Flow | -122,757 | -49,691 | -33,854 | -45,138 |
Cash | 84,378 | 400,283 | 183,049 | 108,345 |
Basic Shares | 81,678 | 86,188 | 77,962 | 75,108 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,000 | $23,385 | $50,931 | $27,941 |
Gross Profit | 7,000 | 19,377 | 50,931 | 27,941 |
EBITDA | -326,975 | -130,421 | -60,401 | -48,543 |
EBIT | -134,429 | -62,502 | -50,268 | |
Net Income | -274,477 | -112,961 | -54,808 | -47,531 |
Net Change In Cash | 7,000 | 23,385 | 50,931 | 27,941 |
Cost of Revenue | -23,414 | 20,009 | ||
Free Cash Flow | -251,441 | -117,592 | -90,618 | -58,423 |
Cash | 84,378 | 157,018 | 68,632 | 92,046 |
Basic Shares | 81,678 | 57,519 | 41,444 | 35,252 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$1.49 |
2024-12-31 | -$1.49 |
2024-09-30 | -$0.60 |
2024-06-30 | -$0.68 |
